Diabetes Drug Shows Promise Against Parkinson's

FRIDAY, Aug. 4, 2017 — The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson’s disease, a new study suggests.
“This is a very promising finding, as the drug holds potential to affect the course of the disease itself,…
Source: Topamax